肝豆灵调控SIRT1/FoxO3信号通路抑制铁死亡改善肝豆状核变性小鼠脑损伤OA
Chinese medicine Gandouling attenuates brain injury in hepatolenticular degeneration mice by inhibiting ferroptosis via the SIRT1/FoxO3 signaling pathway
目的:通过调控沉默信息调节因子 1(SIRT1)/叉头框蛋白质O3(FoxO3)信号通路介导的铁死亡探讨肝豆灵抗肝豆状核变性(又称威尔逊病)脑损伤的作用机制.方法:TX小鼠随机分为六组:模型对照组、肝豆灵组、白藜芦醇(SIRT1激活剂)组、肝豆灵+白藜芦醇组、EX-527(SIRT1抑制剂)组、肝豆灵+EX-527组,DL小鼠作为空白对照组.适应性饲养后,进行四周干预治疗,随后通过莫里斯水迷宫实验、悬挂实验和爬杆实验评估小鼠的神经功能;TUNEL法检测基底节组织细胞凋亡水平;2',7'-二氯荧光素二乙酸酯(DCFH-DA)法分析小鼠基底节组织中活性氧水平,比色法检测基底组织中亚铁离子和丙二醛水平,免疫荧光法测定组织中SIRT1和FoxO3荧光强度,蛋白质印迹法检测SIRT1、FoxO3、谷胱甘肽过氧化物酶4(GPX4)、溶质载体超家族7成员11(SLC7A11)、长链酰基辅酶A合成酶4(ACSL4)、铁蛋白重链1(FTH1)及P53蛋白的表达水平;定量逆转录聚合酶链反应(qRT-PCR)检测Sirt1和Foxo3的mRNA表达.结果:与空白对照组比较,模型对照组神经功能损伤明显(小鼠逃逸时间延长,平台穿越频次减少,抓握评分降低,转向和爬杆时间延长),神经细胞凋亡增加,Sirt1转录和表达水平下降(均P<0.01),Foxo3的转录(P<0.05)和表达水平升高(P<0.01),且小鼠基底节组织中活性氧、亚铁离子、丙二醛水平上升(均P<0.01),抑铁死亡相关蛋白(GPX4、SLC7A11、FTH1)表达水平下降(均P<0.01),促铁死亡相关蛋白(P53、ACSL4)表达水平上升(均P<0.05).肝豆灵和白藜芦醇单独干预后均能显著逆转上述现象,两者效果相当(均P>0.05),且肝豆灵与白藜芦醇联合干预呈现协同增效.EX-527则加剧模型小鼠的神经功能损伤、细胞凋亡和铁死亡(均P<0.05),而肝豆灵与EX-527联用后与模型对照组间的差异无统计学意义(均P>0.05).结论:肝豆灵通过调控SIRT1/FoxO3信号通路抑制模型鼠神经细胞铁死亡的发生,从而改善其神经功能.
Objective:To investigate the mechanism by which the Chinese medicine Gandouling protects against brain injury in hepatolenticular degeneration(Wilson disease)through regulation of the silence information regulator 1(SIRT1)/forkhead box protein O3(FoxO3)pathway-mediated ferroptosis.Methods:TX mice were randomly divided into six groups:model control,Gandouling,resveratrol(SIRT1 activator),Gandouling+resveratrol,EX-527(SIRT1 inhibitor),and Gandouling+EX-527 groups,with DL mice serving as the blank control group.After four weeks of intervention,neurological function was assessed using the Morris water maze test,wire hanging test,and pole test.Apoptosis in basal ganglia tissue was detected by TUNEL assay.Reactive oxygen species(ROS)levels in basal ganglia tissue were measured using the DCFH-DA method,while ferrous iron(Fe²+)and malondialdehyde(MDA)levels were determined by colorimetric assays.Immunofluorescence was used to evaluate the fluorescence intensity of SIRT1 and FoxO3.The protein expression levels of SIRT1,FoxO3,glutathione peroxidase 4(GPX4),solute carrier superfamily 7 member 11(SLC7A11),acid-CoA synthetase long-chain family 4(ACSL4),ferritin heavy chain 1(FTH1),and P53 were assessed by Western blotting,and the Mrna expression levels of Sirt1 and Foxo3 were quantified by Qrt-PCR.Results:Compared with the blank control group,the model control group exhibited significant neurological impairments(prolonged escape latency,reduced platform crossing frequency,decreased grip score and prolonged turning and pole-climbing time),increased neuronal apoptosis,decreased transcription and expression of Sirt1(both P<0.01),increased transcription(P<0.05)and expression(P<0.01)of Foxo3,and elevated levels of ROS,Fe²⁺,and MDA in basal ganglia tissue(all P<0.01).Expression levels of ferroptosis-inhibiting proteins(GPX4,SLC7A11,FTH1)were decreased(all P<0.01),while those of ferroptosis-promoting proteins(P53,ACSL4)were increased(both P<0.05).Both Gandouling and resveratrol monotherapy significantly reversed the above alterations with comparable efficacy between the two treatments(all P>0.05)and combined Gandouling and resveratrol treatment exhibited synergistic effects.EX-527 exacerbated neurological impairments,neuronal apoptosis and ferroptosis(all P<0.05).However,no significant differences were observed between the Gandouling+EX-527 group and the model control group(all P>0.05).Conclusion:Gandouling inhibits neuronal ferroptosis by regulating the SIRT1/FoxO3 signaling pathway,thereby improving neurological function in model mice.
武凯健;王妮;赵大鹏;魏汪云;张婉青;张静
安徽中医药大学第一附属医院脑病一科,安徽 合肥 230031安徽中医药大学第一附属医院脑病一科,安徽 合肥 230031青岛大学附属泰安市中心医院神经内科,山东 泰安 271000安徽中医药大学第一附属医院脑病一科,安徽 合肥 230031安徽中医药大学第一附属医院脑病一科,安徽 合肥 230031安徽中医药大学第一附属医院脑病一科,安徽 合肥 230031
医药卫生
肝豆状核变性威尔逊病肝豆灵神经损伤铁死亡SIRT1/FoxO3信号通路小鼠
Hepatolenticular degenerationWilson diseaseGandoulingInjury of nerveFerroptosisSIRT1/FoxO3 signaling pathwayMice
《浙江大学学报(医学版)》 2026 (3)
198-209,12
安徽省自然科学基金(2508085MH224)国家自然科学基金(82574976)安徽省江淮名医培养工程(ahsjhmypygc20230076)安徽省卫生健康科研项目(AHWJ2024Aa10102)山东省中医药科技项目(M-2022083)This study was supported by Anhui Provincial Natural Science Foundation of China(2508085MH224),National Natural Science Foundation of China(82574976),Anhui Provincial Jianghuai Famous Doctors Training Project(ahsjhmypygc20230076),Anhui Provincial Health Research Project(AHWJ2024Aa10102),and Traditional Chinese Medicine Science and Technology Project of Shandong Province(M-2022083)
评论